Δ9-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture

Neuropharmacology

Volumn 49, Issue 8, 2005, Pages 1170-1177

  Lundberg, Daniel J ^a   Daniel, Andrea R ^a   Thayer, Stanley A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cannabinoid; CB1; Desensitization; Hippocampus; Tetrahydrocannabinol; Win55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BOVINE SERUM ALBUMIN; CALCIUM; DRONABINOL; FATTY ACID; PARTIAL AGONIST;

AGONIST; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; FETUS; HIPPOCAMPUS; LIPID SOLUBILITY; LONG TERM POTENTIATION; MEDICAL ASSESSMENT; NERVE CELL CULTURE; NERVE CELL NETWORK; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ANIMALS; CALCIUM; CANNABINOIDS; CELLS, CULTURED; HALLUCINOGENS; HIPPOCAMPUS; MORPHOLINES; NAPHTHALENES; NEURONS; RATS; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TETRAHYDROCANNABINOL;

EID: 27744574366     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.07.012     Document Type: Article

References (31)

1. C.E. Bass, and B.R. Martin Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice Drug and Alcohol Dependence 60 2000 113 119
2. C.S. Breivogel, and S.R. Childers Cannabinoid agonist signal transduction in rat brain: Comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition Journal of Pharmacology and Experimental Therapeutics 295 2000 328 336
3. C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, L.J. Vogt, and L.J. Sim-Selley Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain Journal of Neurochemistry 73 1999 2447 2459
4. T.H. Burkey, R.M. Quock, P. Consroe, F.J. Ehlert, Y. Hosohata, W.R. Roeske, and H.I. Yamamura Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain European Journal of Pharmacology 336 1997 295 298
5. P.K. Chan, S.C. Chan, and W.H. Yung Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist Neuroreport 9 1998 671 675
6. R.B. Clark, B.J. Knoll, and R. Barber Partial agonists and G protein-coupled receptor desensitization Trends in Pharmacological Sciences 20 1999 279 286
7. A.A. Coutts, S. Anavi-Goffer, R.A. Ross, D.J. MacEwan, K. Mackie, R.G. Pertwee, and A.J. Irving Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons Journal of Neuroscience 21 2001 2425 2433
8. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, A.M. Zimmer, A. Zimmer, and B.R. Martin Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain Journal of Neurochemistry 75 2000 2434 2444
9. M.A. Diana, and A. Marty Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) British Journal of Pharmacology 142 2004 9 19
10. J.A. Dill, and A.C. Howlett Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs Journal of Pharmacology and Experimental Therapeutics 244 1988 1157 1163
11. F. Fan, D.R. Compton, S. Ward, L. Melvin, and B.R. Martin Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212 Journal of Pharmacology and Experimental Therapeutics 271 1994 1383 1390
12. R.R. Gainetdinov, R.T. Premont, L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Desensitization of G protein-coupled receptors and neuronal functions Annual Review of Neuroscience 27 2004 107 144
13. 2+ indicators with greatly improved fluorescence properties Journal of Biological Chemistry 260 1985 3440 3450
14. A.F. Hoffman, M. Oz, T. Caulder, and C.R. Lupica Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure Journal of Neuroscience 23 2003 4815 4820
15. W. Jin, S. Brown, J.P. Roche, C. Hsieh, J.P. Celver, A. Kovoor, C. Chavkin, and K. Mackie Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization Journal of Neuroscience 19 1999 3773 3780
16. M. Kouznetsova, B. Kelley, M. Shen, and S.A. Thayer Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture Molecular Pharmacology 61 2002 477 485
17. T. Luk, W.Z. Jin, A. Zvonok, D. Lu, X.Z. Lin, C. Chavkin, A. Makriyannis, and K. Mackie Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist British Journal of Pharmacology 142 2004 495 500
18. M. Maccarrone, M. Attina, M. Bari, A. Cartoni, C. Ledent, and A. Finazzi-Agro Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages Journal of Neurochemistry 78 2001 339 348
19. K. Mackie, W.A. Devane, and B. Hille Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells Molecular Pharmacology 44 1993 498 503
20. R. Maldonado Study of cannabinoid dependence in animals Pharmacology and Therapeutics 95 2002 153 164
21. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutierrez, M. van der Stelt, M.L. Lopez-Rodriguez, E. Casanova, G. Schutz, W. Zieglgansberger, V. Di Marzo, C. Behl, and B. Lutz CB1 Cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
22. H.J. Matthies, H.C. Palfrey, L.D. Hirning, and R.J. Miller Down regulation of protein kinase C in neuronal cells: effects on neurotransmitter release Journal of Neuroscience 7 1987 1198 1206
23. J.R. McLeod Jr., M. Shen, D.J. Kim, and S.A. Thayer Neurotoxicity mediated by aberrant patterns of synaptic activity between rat hippocampal neurons in culture Journal of Neurophysiology 80 1998 2688 2698
24. 9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture Molecular Pharmacology 55 1999 8 13
25. M. Shen, T.M. Piser, V.S. Seybold, and S.A. Thayer Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures Journal of Neuroscience 16 1996 4322 4334
26. L.J. Sim-Selley Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids Critical Reviews in Neurobiology 15 2003 91 119
27. L.J. Sim-Selley, and B.R. Martin Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice Journal of Pharmacology and Experimental Therapeutics 303 2002 36 44
28. 2+ transients using simultaneous microfluorimetry and electrophysiology Pflugers Archives 412 1988 216 223
29. E.A. Walker, and A.M. Young Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats Psychopharmacology (Berlin) 154 2001 131 142
30. 2+ loads Journal of Neurophysiology 72 1994 2563 2569
31. J.L. Werth, and S.A. Thayer Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons Journal of Neuroscience 14 1994 348 356